MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...
“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...
BEDFORD, Massachusetts, Nov. 20, 2014 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX), today announced the launch of the next-generation NovaSure 6mm global endometrial ablation (GEA) system. The ...
MARLBOROUGH, Mass. — Hologic Inc. (Nasdaq: HOLX), a global leader in women’s health, has announced approval of the NovaSure ® V5 global endometrial ablation (GEA) device in Canada and Europe. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback